LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 7 von insgesamt 7

Suchoptionen

  1. Artikel ; Online: How microcompetition with latent viruses can cause α synuclein aggregation, mitochondrial dysfunction, and eventually Parkinson's disease.

    Polansky, Hanan / Lori, Gillad

    Journal of neurovirology

    2021  Band 27, Heft 1, Seite(n) 52–57

    Abstract: The cause of most Parkinson's disease cases is unknown. However, it is well documented that mitochondrial dysfunction and misfolded α synuclein aggregation are important cellular abnormalities associated with the disease. In this paper, we use the ... ...

    Abstract The cause of most Parkinson's disease cases is unknown. However, it is well documented that mitochondrial dysfunction and misfolded α synuclein aggregation are important cellular abnormalities associated with the disease. In this paper, we use the microcompetition model to show how latent viruses, which infect the central and peripheral nervous systems, can cause the observed mitochondrial dysfunction and excess α synuclein aggregation, and eventually, Parkinson's disease.
    Mesh-Begriff(e) Animals ; Humans ; Latent Infection/metabolism ; Mitochondria/pathology ; Parkinson Disease/pathology ; Protein Aggregation, Pathological/metabolism ; Protein Aggregation, Pathological/pathology ; Virus Latency/physiology ; Viruses/metabolism ; alpha-Synuclein/metabolism
    Chemische Substanzen alpha-Synuclein
    Sprache Englisch
    Erscheinungsdatum 2021-01-06
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1283265-0
    ISSN 1538-2443 ; 1355-0284
    ISSN (online) 1538-2443
    ISSN 1355-0284
    DOI 10.1007/s13365-020-00929-x
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.

    Polansky, Hanan / Lori, Gillad

    Journal of evidence-based integrative medicine

    2020  Band 25, Seite(n) 2515690X20932523

    Abstract: The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the ... ...

    Abstract The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the development of such treatment, pharmaceutical companies and government agencies are currently testing several existing drugs for their effect on the virus. Gene-Eden-VIR and Novirin are natural, broad-spectrum, antiviral treatments proven to be safe and effective in several clinical studies. In this article, we present evidence indicating that the 5 Gene-Eden-VIR/Novirin ingredients have anti-betacoronavirus, and specifically, anti-SARS-CoV effects. We consider this evidence as a first indication of the anti-coronavirus effects of Gene-Eden-VIR/Novirin. Next, we are planning to conduct a clinical study with users of the treatments to test the effects of Gene-Eden-VIR/Novirin on individuals at risk and those infected with the virus.
    Mesh-Begriff(e) Antiviral Agents/therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus/drug effects ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Drug Combinations ; Humans ; Pandemics ; Plant Extracts/therapeutic use ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Quercetin/therapeutic use ; SARS-CoV-2 ; Selenium/therapeutic use
    Chemische Substanzen Antiviral Agents ; Drug Combinations ; Gene-Eden-VIR ; Plant Extracts ; Quercetin (9IKM0I5T1E) ; Selenium (H6241UJ22B)
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-06-18
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ISSN 2515-690X
    ISSN (online) 2515-690X
    DOI 10.1177/2515690X20932523
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.

    Polansky, Hanan / Lori, Gillad

    International journal of antimicrobial agents

    2020  Band 55, Heft 6, Seite(n) 105971

    Mesh-Begriff(e) Antiviral Agents/pharmacology ; Betacoronavirus/drug effects ; Coronavirus Infections/drug therapy ; Drug Combinations ; Humans ; Pandemics ; Plant Extracts/pharmacology ; Pneumonia, Viral/drug therapy ; Quercetin/pharmacology ; Selenium/pharmacology
    Chemische Substanzen Antiviral Agents ; Drug Combinations ; Gene-Eden-VIR ; Plant Extracts ; Quercetin (9IKM0I5T1E) ; Selenium (H6241UJ22B)
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-04-10
    Erscheinungsland Netherlands
    Dokumenttyp Letter
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/j.ijantimicag.2020.105971
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection

    Polansky, Hanan / Lori, Gillad

    Int J Antimicrob Agents

    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #143399
    Datenquelle COVID19

    Kategorien

  5. Artikel: Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19

    Polansky, Hanan / Lori, Gillad

    J Evid Based Integr Med

    Abstract: The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the ... ...

    Abstract The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the development of such treatment, pharmaceutical companies and government agencies are currently testing several existing drugs for their effect on the virus. Gene-Eden-VIR and Novirin are natural, broad-spectrum, antiviral treatments proven to be safe and effective in several clinical studies. In this article, we present evidence indicating that the 5 Gene-Eden-VIR/Novirin ingredients have anti-betacoronavirus, and specifically, anti-SARS-CoV effects. We consider this evidence as a first indication of the anti-coronavirus effects of Gene-Eden-VIR/Novirin. Next, we are planning to conduct a clinical study with users of the treatments to test the effects of Gene-Eden-VIR/Novirin on individuals at risk and those infected with the virus.
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #32551855
    Datenquelle COVID19

    Kategorien

  6. Artikel ; Online: Effects of Gene-Eden-VIR and Novirin on SARS-CoV

    Polansky, Hanan / Lori, Gillad

    Journal of Evidence-Based Integrative Medicine

    Implications for COVID-19

    2020  Band 25, Seite(n) 2515690X2093252

    Abstract: The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the ... ...

    Abstract The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the development of such treatment, pharmaceutical companies and government agencies are currently testing several existing drugs for their effect on the virus. Gene-Eden-VIR and Novirin are natural, broad-spectrum, antiviral treatments proven to be safe and effective in several clinical studies. In this article, we present evidence indicating that the 5 Gene-Eden-VIR/Novirin ingredients have anti-betacoronavirus, and specifically, anti-SARS-CoV effects. We consider this evidence as a first indication of the anti-coronavirus effects of Gene-Eden-VIR/Novirin. Next, we are planning to conduct a clinical study with users of the treatments to test the effects of Gene-Eden-VIR/Novirin on individuals at risk and those infected with the virus.
    Schlagwörter covid19
    Sprache Englisch
    Verlag SAGE Publications
    Erscheinungsland us
    Dokumenttyp Artikel ; Online
    ISSN 2515-690X
    DOI 10.1177/2515690x20932523
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Coronavirus disease 2019 (COVID-19)

    Polansky, Hanan / Lori, Gillad

    International Journal of Antimicrobial Agents

    first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection

    2020  Band 55, Heft 6, Seite(n) 105971

    Schlagwörter Microbiology (medical) ; Pharmacology (medical) ; Infectious Diseases ; General Medicine ; covid19
    Sprache Englisch
    Verlag Elsevier BV
    Erscheinungsland us
    Dokumenttyp Artikel ; Online
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/j.ijantimicag.2020.105971
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang